Refractories Market Size, Share & Trends Analysis Report By End Use (Iron & Steel, Cement & Lime, Glass & Ceramics, Non-Ferrous Metals), By Region (North America, Europe, APAC, Latin America, MEA), And Segment Forecasts, 2026 - 2033
Description
Refractories Market Summary
The global refractories market size was estimated at USD 47.88 billion in 2025 and is projected to reach USD 95.96 billion by 2033, growing at a CAGR of 9.5% from 2026 to 2033. Crude steel manufacturing through basic oxygen furnaces (BOF), electric arc furnaces (EAF), and induction furnaces (IF) requires high volumes of shaped and unshaped refractories to withstand extreme temperatures and chemical wear.
As countries such as India, China, and Vietnam ramp up infrastructure and construction projects, steel demand and, thus, refractories continue to rise. Additionally, green steel initiatives in Europe and Asia encourage investments in new EAF setups, further strengthening refractory consumption.
Cement kilns operate at temperatures exceeding 1400°C, demanding consistent refractory lining replacement. Rapid urbanization and population growth in the Asia Pacific and Africa are fueling the construction of roads, bridges, residential, and commercial buildings, which translates to higher cement output. Moreover, capacity expansion plans by major cement producers in countries like India, Indonesia, and Nigeria are boosting demand for basic and non-basic refractories.
Rising demand from the non-ferrous metals industry is also contributing to market growth. Copper, aluminum, zinc, and nickel smelters require specialized refractory linings to handle chemically aggressive slags and high thermal loads. As energy transition efforts accelerate, demand for these metals in EV batteries, wind turbines, and solar panels increases. This is pushing companies in regions such as Latin America, Africa, and Australia to invest in expanding and upgrading their smelting facilities, driving consistent refractory usage.
The growing role of refractories in waste-to-energy (WTE), glass, and petrochemical industries is enhancing market diversity. Incineration plants and biomass-based energy units rely on refractory linings to prevent structural degradation. Similarly, glass furnaces and chemical reactors are lined with high-grade refractories to ensure operational efficiency and reduce maintenance downtimes. Rising environmental awareness and stricter waste disposal norms increase investments in these sectors, reinforcing long-term refractory demand.
Lastly, technological advancements and product innovation are reshaping the market. Manufacturers focus on high-performance monolithic refractories, castables, and precast shapes that offer better energy efficiency and longer service life. Demand for recyclable, low-carbon, and energy-efficient materials also influences product design, especially in Europe and North America. Digitalization in refractory monitoring and predictive maintenance further supports their adoption in advanced industrial operations, making the sector more resilient and future-ready.
Global Refractories Market Report Segmentation
This report forecasts revenue and volume growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global refractories market report based on end use and region.
The global refractories market size was estimated at USD 47.88 billion in 2025 and is projected to reach USD 95.96 billion by 2033, growing at a CAGR of 9.5% from 2026 to 2033. Crude steel manufacturing through basic oxygen furnaces (BOF), electric arc furnaces (EAF), and induction furnaces (IF) requires high volumes of shaped and unshaped refractories to withstand extreme temperatures and chemical wear.
As countries such as India, China, and Vietnam ramp up infrastructure and construction projects, steel demand and, thus, refractories continue to rise. Additionally, green steel initiatives in Europe and Asia encourage investments in new EAF setups, further strengthening refractory consumption.
Cement kilns operate at temperatures exceeding 1400°C, demanding consistent refractory lining replacement. Rapid urbanization and population growth in the Asia Pacific and Africa are fueling the construction of roads, bridges, residential, and commercial buildings, which translates to higher cement output. Moreover, capacity expansion plans by major cement producers in countries like India, Indonesia, and Nigeria are boosting demand for basic and non-basic refractories.
Rising demand from the non-ferrous metals industry is also contributing to market growth. Copper, aluminum, zinc, and nickel smelters require specialized refractory linings to handle chemically aggressive slags and high thermal loads. As energy transition efforts accelerate, demand for these metals in EV batteries, wind turbines, and solar panels increases. This is pushing companies in regions such as Latin America, Africa, and Australia to invest in expanding and upgrading their smelting facilities, driving consistent refractory usage.
The growing role of refractories in waste-to-energy (WTE), glass, and petrochemical industries is enhancing market diversity. Incineration plants and biomass-based energy units rely on refractory linings to prevent structural degradation. Similarly, glass furnaces and chemical reactors are lined with high-grade refractories to ensure operational efficiency and reduce maintenance downtimes. Rising environmental awareness and stricter waste disposal norms increase investments in these sectors, reinforcing long-term refractory demand.
Lastly, technological advancements and product innovation are reshaping the market. Manufacturers focus on high-performance monolithic refractories, castables, and precast shapes that offer better energy efficiency and longer service life. Demand for recyclable, low-carbon, and energy-efficient materials also influences product design, especially in Europe and North America. Digitalization in refractory monitoring and predictive maintenance further supports their adoption in advanced industrial operations, making the sector more resilient and future-ready.
Global Refractories Market Report Segmentation
This report forecasts revenue and volume growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global refractories market report based on end use and region.
- End Use Outlook (Revenue, USD Million; Volume, Kilotons; 2021 - 2033)
- Iron & Steel
- Cement & Lime
- Glass & Ceramics
- Non-Ferrous Metals
- Others
- Regional Outlook (Revenue, USD Million; Volume, Kilotons; 2021 - 2033)
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- Russia
- France
- Asia Pacific
- China
- India
- Japan
- Latin America
- South Korea
- Brazil
- Middle East & Africa
- Saudi Africa
Table of Contents
100 Pages
- Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Segment Definitions
- 1.2.1. Therapy
- 1.2.2. Route of Administration
- 1.2.3. Distribution Channel
- 1.3. Estimates and Forecast Timeline
- 1.4. Research Methodology
- 1.5. Information Procurement
- 1.5.1. Purchased Database
- 1.5.2. GVR’s Internal Database
- 1.5.3. Secondary Sources
- 1.5.4. Primary Research
- 1.6. Information Analysis
- 1.6.1. Data Analysis Models
- 1.7. Market Formulation & Data Visualization
- 1.8. Model Details
- 1.8.1. Commodity Flow Analysis
- 1.9. List of Secondary Sources
- 1.10. Objectives
- Chapter 2. Executive Summary
- 2.1. Market Snapshot
- 2.2. Segment Snapshot
- 2.3. Competitive Landscape Snapshot
- Chapter 3. Head and Neck Cancer Therapeutics Market Variables, Trends, & Scope
- 3.1. Market Lineage Outlook
- 3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.2. Market Restraint Analysis
- 3.3. Business Environment Analysis
- 3.3.1. Industry Analysis - Porter’s Five Forces Analysis
- 3.3.1.1. Supplier Power
- 3.3.1.2. Buyer Power
- 3.3.1.3. Substitution Threat
- 3.3.1.4. Threat of New Entrants
- 3.3.1.5. Competitive Rivalry
- 3.3.2. PESTLE Analysis
- 3.3.3. Pipeline Analysis
- 3.3.4. Patent Expiry Analysis
- 3.3.5. Pricing Analysis
- Chapter 4. Head and Neck Cancer Therapeutics Market: Therapy Business Analysis
- 4.1. Therapy Market Share, 2025 & 2033
- 4.2. Therapy Segment Dashboard
- 4.3. Market Size & Forecasts and Trend Analysis, by Therapy, 2021 to 2033 (USD Million)
- 4.4. Chemotherapy
- 4.4.1. Chemotherapy Market, 2021 - 2033 (USD Million)
- 4.5. Immunotherapy
- 4.5.1. Immunotherapy Market, 2021 - 2033 (USD Million)
- 4.6. Targeted Therapy
- 4.6.1. Targeted Therapy Market, 2021 - 2033 (USD Million)
- Chapter 5. Head and Neck Cancer Therapeutics Market: Route of Administration Business Analysis
- 5.1. Route of Administration Market Share, 2025 & 2033
- 5.2. Route of Administration Segment Dashboard
- 5.3. Market Size & Forecasts and Trend Analysis, by Route of administration, 2021 to 2033 (USD Million)
- 5.4. Injectable
- 5.4.1. Injectable Market, 2021 - 2033 (USD Million)
- 5.5. Oral
- 5.5.1. Oral Market, 2021 - 2033 (USD Million)
- Chapter 6. Head and Neck Cancer Therapeutics Market: Distribution Channel Business Analysis
- 6.1. Distribution Channel Market Share, 2025 & 2033
- 6.2. Distribution Channel Segment Dashboard
- 6.3. Market Size & Forecasts and Trend Analysis, by Distribution channel, 2021 to 2033 (USD Million)
- 6.4. Retail and Specialty Pharmacies
- 6.4.1. Retail and Specialty Pharmacies Market, 2021 - 2033 (USD Million)
- 6.5. Hospital Pharmacies
- 6.5.1. Hospital Pharmacies Market, 2021 - 2033 (USD Million)
- 6.6. Online Pharmacies
- 6.6.1. Online Pharmacies Market, 2021 - 2033 (USD Million)
- Chapter 7. Head and Neck Cancer Therapeutics Market: Regional Estimates & Trend Analysis
- 7.1. Regional Market Share Analysis, 2025 & 2033
- 7.2. Regional Market Dashboard
- 7.3. Market Size & Forecasts Trend Analysis, 2021 to 2033:
- 7.4. North America
- 7.4.1. North America Head and Neck Cancer Therapeutics Market Estimates and Forecasts, By Country, 2021 - 2033 (USD Million)
- 7.4.2. U.S.
- 7.4.2.1. Key Country Dynamics
- 7.4.2.2. Disease Prevalence
- 7.4.2.3. Regulatory Framework
- 7.4.2.4. Reimbursement Framework
- 7.4.2.5. U.S. Head and Neck Cancer Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.4.3. Canada
- 7.4.3.1. Key Country Dynamics
- 7.4.3.2. Disease Prevalence
- 7.4.3.3. Regulatory Framework
- 7.4.3.4. Reimbursement Framework
- 7.4.3.5. U.S. Head and Neck Cancer Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.4.4. Mexico
- 7.4.4.1. Key Country Dynamics
- 7.4.4.2. Disease Prevalence
- 7.4.4.3. Regulatory Framework
- 7.4.4.4. Reimbursement Framework
- 7.4.4.5. Mexico Head and Neck Cancer Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.5. Europe
- 7.5.1. Europe Head and Neck Cancer Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.5.2. UK
- 7.5.2.1. Key Country Dynamics
- 7.5.2.2. Disease Prevalence
- 7.5.2.3. Regulatory Framework
- 7.5.2.4. Reimbursement Framework
- 7.5.2.5. Uk Head and Neck Cancer Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.5.3. Germany
- 7.5.3.1. Key Country Dynamics
- 7.5.3.2. Disease Prevalence
- 7.5.3.3. Regulatory Framework
- 7.5.3.4. Reimbursement Framework
- 7.5.3.5. Germany Head and Neck Cancer Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.5.4. France
- 7.5.4.1. Key Country Dynamics
- 7.5.4.2. Disease Prevalence
- 7.5.4.3. Regulatory Framework
- 7.5.4.4. Reimbursement Framework
- 7.5.4.5. France Head and Neck Cancer Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.5.5. Italy
- 7.5.5.1. Key Country Dynamics
- 7.5.5.2. Disease Prevalence
- 7.5.5.3. Regulatory Framework
- 7.5.5.4. Reimbursement Framework
- 7.5.5.5. Italy Head and Neck Cancer Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.5.6. Spain
- 7.5.6.1. Key Country Dynamics
- 7.5.6.2. Disease Prevalence
- 7.5.6.3. Regulatory Framework
- 7.5.6.4. Reimbursement Framework
- 7.5.6.5. Spain Head and Neck Cancer Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.5.7. Denmark
- 7.5.7.1. Key Country Dynamics
- 7.5.7.2. Disease Prevalence
- 7.5.7.3. Regulatory Framework
- 7.5.7.4. Reimbursement Framework
- 7.5.7.5. Denmark Head and Neck Cancer Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.5.8. Sweden
- 7.5.8.1. Key Country Dynamics
- 7.5.8.2. Disease Prevalence
- 7.5.8.3. Regulatory Framework
- 7.5.8.4. Reimbursement Framework
- 7.5.8.5. Sweden Head and Neck Cancer Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.5.9. Norway
- 7.5.9.1. Key Country Dynamics
- 7.5.9.2. Disease Prevalence
- 7.5.9.3. Regulatory Framework
- 7.5.9.4. Reimbursement Framework
- 7.5.9.5. Norway Head and Neck Cancer Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.6. Asia Pacific
- 7.6.1. Asia Pacific Head and Neck Cancer Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.6.2. Japan
- 7.6.2.1. Key Country Dynamics
- 7.6.2.2. Disease Prevalence
- 7.6.2.3. Regulatory Framework
- 7.6.2.4. Reimbursement Framework
- 7.6.2.5. Japan Head and Neck Cancer Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.6.3. China
- 7.6.3.1. Key Country Dynamics
- 7.6.3.2. Disease Prevalence
- 7.6.3.3. Regulatory Framework
- 7.6.3.4. Reimbursement Framework
- 7.6.3.5. China Head and Neck Cancer Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.6.4. India
- 7.6.4.1. Key Country Dynamics
- 7.6.4.2. Disease Prevalence
- 7.6.4.3. Regulatory Framework
- 7.6.4.4. Reimbursement Framework
- 7.6.4.5. India Head and Neck Cancer Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.6.5. Australia
- 7.6.5.1. Key Country Dynamics
- 7.6.5.2. Disease Prevalence
- 7.6.5.3. Regulatory Framework
- 7.6.5.4. Reimbursement Framework
- 7.6.5.5. Australia Head and Neck Cancer Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.6.6. South Korea
- 7.6.6.1. Key Country Dynamics
- 7.6.6.2. Disease Prevalence
- 7.6.6.3. Regulatory Framework
- 7.6.6.4. Reimbursement Framework
- 7.6.6.5. South Korea Head and Neck Cancer Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.6.7. Thailand
- 7.6.7.1. Key Country Dynamics
- 7.6.7.2. Disease Prevalence
- 7.6.7.3. Regulatory Framework
- 7.6.7.4. Reimbursement Framework
- 7.6.7.5. Thailand Head and Neck Cancer Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.7. Latin America
- 7.7.1. Latin America Head and Neck Cancer Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.7.2. Brazil
- 7.7.2.1. Key Country Dynamics
- 7.7.2.2. Disease Prevalence
- 7.7.2.3. Regulatory Framework
- 7.7.2.4. Reimbursement Framework
- 7.7.2.5. Japan Head and Neck Cancer Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.7.3. Argentina
- 7.7.3.1. Key Country Dynamics
- 7.7.3.2. Disease Prevalence
- 7.7.3.3. Regulatory Framework
- 7.7.3.4. Reimbursement Framework
- 7.7.3.5. China Head and Neck Cancer Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.8. Middle East and Africa
- 7.8.1. Middle East and Africa Head and Neck Cancer Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.8.2. South Africa
- 7.8.2.1. Key Country Dynamics
- 7.8.2.2. Disease Prevalence
- 7.8.2.3. Regulatory Framework
- 7.8.2.4. Reimbursement Framework
- 7.8.2.5. South Africa Head and Neck Cancer Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.8.3. Saudi Arabia
- 7.8.3.1. Key Country Dynamics
- 7.8.3.2. Disease Prevalence
- 7.8.3.3. Regulatory Framework
- 7.8.3.4. Reimbursement Framework
- 7.8.3.5. Saudi Arabia Head and Neck Cancer Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.8.4. UAE
- 7.8.4.1. Key Country Dynamics
- 7.8.4.2. Disease Prevalence
- 7.8.4.3. Regulatory Framework
- 7.8.4.4. Reimbursement Framework
- 7.8.4.5. UAE Head and Neck Cancer Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.8.5. Kuwait
- 7.8.5.1. Key Country Dynamics
- 7.8.5.2. Disease Prevalence
- 7.8.5.3. Regulatory Framework
- 7.8.5.4. Reimbursement Framework
- 7.8.5.5. Kuwait Head and Neck Cancer Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- Chapter 8. Competitive Landscape
- 8.1. Participant Overview
- 8.2. Company Market Position Analysis
- 8.3. Company Categorization
- 8.4. Strategy Mapping
- 8.5. Company Profiles/Listing
- 8.5.1. Eli Lilly and Company
- 8.5.1.1. Overview
- 8.5.1.2. Financial Performance
- 8.5.1.3. Therapy Benchmarking
- 8.5.1.4. Strategic Initiatives
- 8.5.2. Sanofi
- 8.5.2.1. Overview
- 8.5.2.2. Financial Performance
- 8.5.2.3. Therapy Benchmarking
- 8.5.2.4. Strategic Initiatives
- 8.5.3. Merck & Co., Inc.
- 8.5.3.1. Overview
- 8.5.3.2. Financial Performance
- 8.5.3.3. Therapy Benchmarking
- 8.5.3.4. Strategic Initiatives
- 8.5.4. Cumberland Pharmaceuticals Inc.
- 8.5.4.1. Overview
- 8.5.4.2. Financial Performance
- 8.5.4.3. Therapy Benchmarking
- 8.5.4.4. Strategic Initiatives
- 8.5.5. Bristol-Myers Squibb Company
- 8.5.5.1. Overview
- 8.5.5.2. Financial Performance
- 8.5.5.3. Therapy Benchmarking
- 8.5.5.4. Strategic Initiatives
- 8.5.6. AstraZeneca
- 8.5.6.1. Overview
- 8.5.6.2. Financial Performance
- 8.5.6.3. Therapy Benchmarking
- 8.5.6.4. Strategic Initiatives
- 8.5.7. Takeda Pharmaceutical Company Limited
- 8.5.7.1. Overview
- 8.5.7.2. Financial Performance
- 8.5.7.3. Therapy Benchmarking
- 8.5.7.4. Strategic Initiatives
- 8.5.8. Teva Pharmaceutical Industries Ltd.
- 8.5.8.1. Overview
- 8.5.8.2. Financial Performance
- 8.5.8.3. Therapy Benchmarking
- 8.5.8.4. Strategic Initiatives
- 8.5.9. F. Hoffmann-La Roche Ltd.
- 8.5.9.1. Overview
- 8.5.9.2. Financial Performance
- 8.5.9.3. Therapy Benchmarking
- 8.5.9.4. Strategic Initiatives
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
